The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, Y.
Right arrow Articles by Shaw, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, Y.
Right arrow Articles by Shaw, S.

The Journal of Immunology, Vol 143, Issue 8 2457-2463, Copyright © 1989 by American Association of Immunologists

ARTICLES

Dual role of the CD44 molecule in T cell adhesion and activation

Y Shimizu, GA Van Seventer, R Siraganian, L Wahl and S Shaw
Experimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892.

Studies of T cell adhesion and activation reveal two new functions of the CD44 molecule, a molecule now recognized to be identical to three molecules of functional interest: Pgp-1, Hermes, and extracellular matrix receptor type III (ECMRIII). By screening for mAb which inhibit T cell adhesion to E, we have identified a functionally unique CD44- specific mAb, NIH44-1, which partially inhibits T cell rosetting by binding to CD44 on the E. NIH44-1, which immunoprecipitates a protein of 85 to 110 kDa with broad tissue distribution, was determined to be specific for CD44 based on comparison of its tissue distribution with multiple CD44-specific reference mAb and sequential immunoprecipitation with such mAb. Anticipating a role for many adhesion molecules in signal transduction, we studied the effect of CD44 mAb on T cell activation and observed that CD44 mAb dramatically augments T cell proliferation induced by CD3- and CD2-receptor-mediated activation. The augmentation of the response to immobilized CD3 mAb by exhaustively monocyte-depleted T cells indicates that augmentation can be mediated by binding to the T cell. Thus, our studies demonstrate specific new roles for CD44 in T cell adhesion and activation. Furthermore, we suggest that: 1) CD44 has a role in adhesion of cells of multiple lineages; and 2) CD44 may participate in adhesion not (only) by functioning as an adhesion receptor but rather by serving as an anchorage site for other adhesion molecules.


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
V. L. Hegde, N. P. Singh, P. S. Nagarkatti, and M. Nagarkatti
CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activation
J. Leukoc. Biol., July 1, 2008; 84(1): 134 - 142.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Rana, S. N. Byrne, L. J. MacDonald, C. Y.-Y. Chan, and G. M. Halliday
Ultraviolet B Suppresses Immunity by Inhibiting Effector and Memory T Cells
Am. J. Pathol., April 1, 2008; 172(4): 993 - 1004.
[Abstract] [Full Text] [PDF]

Home page
 Am J Sports MedHome page
T. Yamada, M. Gotoh, K. Nakama, Y. Mitsui, F. Higuchi, and K. Nagata
Effects of Hyaluronan on Cell Proliferation and mRNA Expression of Procollagens {alpha}1 (I) and {alpha}1 (III) in Tendon-Derived Fibroblasts From Patients With Rotator Cuff Disease: An In Vitro Study
Am. J. Sports Med., November 1, 2007; 35(11): 1870 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Larkin, G. J. Renukaradhya, V. Sriram, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz
CD44 Differentially Activates Mouse NK T Cells and Conventional T Cells
J. Immunol., July 1, 2006; 177(1): 268 - 279.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. P. Mishra, S. Mishra, K. Gee, and A. Kumar
Differential Involvement of Calmodulin-dependent Protein Kinase II-activated AP-1 and c-Jun N-terminal Kinase-activated EGR-1 Signaling Pathways in Tumor Necrosis Factor-{alpha} and Lipopolysaccharide-induced CD44 Expression in Human Monocytic Cells
J. Biol. Chem., July 22, 2005; 280(29): 26825 - 26837.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
Y. Do, A. Q. Rafi-Janajreh, R. J. Mckallip, P. S. Nagarkatti, and M. Nagarkatti
Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease
Int. Immunol., November 1, 2003; 15(11): 1327 - 1340.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H. Xu, A. Manivannan, J. Liversidge, P. F. Sharp, J. V. Forrester, and I. J. Crane
Involvement of CD44 in leukocyte trafficking at the blood-retinal barrier
J. Leukoc. Biol., December 1, 2002; 72(6): 1133 - 1141.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Gee, W. Lim, W. Ma, D. Nandan, F. Diaz-Mitoma, M. Kozlowski, and A. Kumar
Differential Regulation of CD44 Expression by Lipopolysaccharide (LPS) and TNF-{alpha} in Human Monocytic Cells: Distinct Involvement of c-Jun N-Terminal Kinase in LPS-Induced CD44 Expression
J. Immunol., November 15, 2002; 169(10): 5660 - 5672.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Khaldoyanidi, S. Karakhanova, J. Sleeman, P. Herrlich, and H. Ponta
CD44 variant-specific antibodies trigger hemopoiesis by selective release of cytokines from bone marrow macrophages
Blood, May 13, 2002; 99(11): 3955 - 3961.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Suzuki, H. Kobayashi, M. Fujie, T. Nishida, M. Takigawa, N. Kanayama, and T. Terao
Kunitz-type Protease Inhibitor Bikunin Disrupts Phorbol Ester-induced Oligomerization of CD44 Variant Isoforms Containing Epitope v9 and Subsequently Suppresses Expression of Urokinase-type Plasminogen Activator in Human Chondrosarcoma Cells
J. Biol. Chem., March 1, 2002; 277(10): 8022 - 8032.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Kuniyasu, N. Oue, M. Tsutsumi, E. Tahara, and W. Yasui
Heparan Sulfate Enhances Invasion by Human Colon Carcinoma Cell Lines through Expression of CD44 Variant Exon 3
Clin. Cancer Res., December 1, 2001; 7(12): 4067 - 4072.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Fiorucci, A. Mencarelli, B. Palazzetti, E. Distrutti, N. Vergnolle, M. D. Hollenberg, J. L. Wallace, A. Morelli, and G. Cirino
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis
PNAS, November 20, 2001; 98(24): 13936 - 13941.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. L. Blass, E. Pure, and C. A. Hunter
A Role for CD44 in the Production of IFN-{{gamma}} and Immunopathology During Infection with Toxoplasma gondii
J. Immunol., May 1, 2001; 166(9): 5726 - 5732.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Visintin, A. Mazzoni, J. H. Spitzer, D. H. Wyllie, S. K. Dower, and D. M. Segal
Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells
J. Immunol., January 1, 2001; 166(1): 249 - 255.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Drillenburg and S. T. Pals
Cell adhesion receptors in lymphoma dissemination
Blood, March 15, 2000; 95(6): 1900 - 1910.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. Seiter, D.-S. Schmidt, and M. Zoller
The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities
Int. Immunol., January 1, 2000; 12(1): 37 - 49.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. L. W. Van Hal, G. A. M. S. Van Dongen, C. B. M. Ten Brink, K.-H. Heider, I. Rech-Weichselbraun, G. B. Snow, and R. H. Brakenhoff
Evaluation of Soluble CD44v6 as a Potential Serum Marker for Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., November 1, 1999; 5(11): 3534 - 3541.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. A. de la Motte, V. C. Hascall, A. Calabro, B. Yen-Lieberman, and S. A. Strong
Mononuclear Leukocytes Preferentially Bind via CD44 to Hyaluronan on Human Intestinal Mucosal Smooth Muscle Cells after Virus Infection or Treatment with Poly(I{middle dot}C)
J. Biol. Chem., October 22, 1999; 274(43): 30747 - 30755.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. L. Hengel, B. M. Jones, M. S. Kennedy, M. R. Hubbard, and J. S. McDougal
Markers of Lymphocyte Homing Distinguish CD4 T Cell Subsets That Turn Over in Response to HIV-1 Infection in Humans
J. Immunol., September 15, 1999; 163(6): 3539 - 3548.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Fujisaki, Y. Tanaka, K. Fujii, S. Mine, K. Saito, S. Yamada, U. Yamashita, T. Irimura, and S. Eto
CD44 Stimulation Induces Integrin-mediated Adhesion of Colon Cancer Cell Lines to Endothelial Cells by Up-Regulation of Integrins and c-Met and Activation of Integrins
Cancer Res., September 1, 1999; 59(17): 4427 - 4434.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Ishiwatari-Hayasaka, T. Fujimoto, T. Osawa, T. Hirama, N. Toyama-Sorimachi, and M. Miyasaka
Requirements for Signal Delivery Through CD44: Analysis Using CD44-Fas Chimeric Proteins
J. Immunol., August 1, 1999; 163(3): 1258 - 1264.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Fujii, Y. Tanaka, S. Hubscher, K. Saito, T. Ota, and S. Eto
Cross-Linking of CD44 on Rheumatoid Synovial Cells Up-Regulates VCAM-1
J. Immunol., February 15, 1999; 162(4): 2391 - 2398.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. A. Wolff, B. Greenfield, D. D. Taub, W. J. Murphy, K. L. Bennett, and A. Aruffo
Generation of Artificial Proteoglycans Containing Glycosaminoglycan-modified CD44. DEMONSTRATION OF THE INTERACTION BETWEEN RANTES AND CHONDROITIN SULFATE
J. Biol. Chem., January 22, 1999; 274(4): 2518 - 2524.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. C. Foster, B. M. Arkonac, N. E. S. Sibinga, C. Shi, M. A. Perrella, and E. Haber
Regulation of CD44 Gene Expression by the Proinflammatory Cytokine Interleukin-1beta in Vascular Smooth Muscle Cells
J. Biol. Chem., August 7, 1998; 273(32): 20341 - 20346.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Yakushijin, J. Steckel, S. Kharbanda, R. Hasserjian, D. Neuberg, W.-m. Jiang, I. Anderson, and M. A. Shipp
A Directly Spliced Exon 10-Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma
Blood, June 1, 1998; 91(11): 4282 - 4291.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Ilangumaran, A. Briol, and D. C. Hoessli
CD44 Selectively Associates With Active Src Family Protein Tyrosine Kinases Lck and Fyn in Glycosphingolipid-Rich Plasma Membrane Domains of Human Peripheral Blood Lymphocytes
Blood, May 15, 1998; 91(10): 3901 - 3908.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
Q. Yu, B. P. Toole, and I. Stamenkovic
Induction of Apoptosis of Metastatic Mammary Carcinoma Cells In Vivo by Disruption of Tumor Cell Surface CD44 Function
J. Exp. Med., December 15, 1997; 186(12): 1985 - 1996.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Schmits, J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al.
CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity
Blood, September 15, 1997; 90(6): 2217 - 2233.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Zoller, A. Schmidt, A. Denzel, and J. Moll
Constitutive Expression of a CD44 Variant Isoform on T Cells Facilitates Regaining of Immunocompetence in Allogeneic Bone Marrow Transplantation
Blood, July 15, 1997; 90(2): 873 - 885.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
J. M. Weiss, J. Sleeman, A. C. Renkl, H. Dittmar, C. C. Termeer, S. Taxis, N. Howells, M. Hofmann, G. Kohler, E. Schopf, et al.
An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function
J. Cell Biol., June 2, 1997; 137(5): 1137 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
G Kaya, I Rodriguez, J L Jorcano, P Vassalli, and I Stamenkovic
Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation.
Genes & Dev., April 15, 1997; 11(8): 996 - 1007.
[Abstract] [PDF]

Home page
 BloodHome page
A. Rafi, M. Nagarkatti, and P. S. Nagarkatti
Hyaluronate-CD44 Interactions Can Induce Murine B-Cell Activation
Blood, April 15, 1997; 89(8): 2901 - 2908.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
D. D. Taylor, C. Gercel-Taylor, and S. A. Gall
Expression and Shedding of CD44 Variant Isoforms in Patients With Gynecologic Malignancies
Reproductive Sciences, September 1, 1996; 3(5): 289 - 294.
[Abstract] [PDF]

Home page
 JDRHome page
S. Murakami, T. Saho, A. Asari, E. Hino, D. Kasai, Y. Shimabukuro, and H. Okada
CD44-Hyaluronate Interaction Participates in the Adherence of T-lymphocytes to Gingival Fibroblasts
Journal of Dental Research, August 1, 1996; 75(8): 1545 - 1552.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
K. Takahashi, I. Stamenkovic, M. Cutler, A. Dasgupta, and K. K. Tanabe
Keratan Sulfate Modification of CD44 Modulates Adhesion to Hyaluronate
J. Biol. Chem., April 19, 1996; 271(16): 9490 - 9496.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. E. I. Taher, L. Smit, A. W. Griffioen, E. J. M. Schilder-Tol, J. Borst, and S. T. Pals
Signaling through CD44 Is Mediated by Tyrosine Kinases
J. Biol. Chem., February 2, 1996; 271(5): 2863 - 2867.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Toyama-Sorimachi, H. Sorimachi, Y. Tobita, F. Kitamura, H. Yagita, K. Suzuki, and M. Miyasaka
A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan
J. Biol. Chem., March 31, 1995; 270(13): 7437 - 7444.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A Bartolazzi, D Jackson, K Bennett, A Aruffo, R Dickinson, J Shields, N Whittle, and I Stamenkovic
Regulation of growth and dissemination of a human lymphoma by CD44 splice variants
J. Cell Sci., January 4, 1995; 108(4): 1723 - 1733.
[Abstract] [PDF]

Home page
 J. Cell Sci.Home page
L. Milstone, L Hough-Monroe, L. Kugelman, J. Bender, and J. Haggerty
Epican, a heparan/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion
J. Cell Sci., January 11, 1994; 107(11): 3183 - 3190.
[Abstract] [PDF]

Home page
 CROBMHome page
C. N. Bertolami and D. V. Messadi
The Role of Proteoglycans in Hard and Soft Tissue Repair
Critical Reviews in Oral Biology & Medicine, January 1, 1994; 5(3): 311 - 337.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
R Arch, K Wirth, M Hofmann, H Ponta, S Matzku, P Herrlich, and M Zoller
Participation in normal immune responses of a metastasis-inducing splice variant of CD44
Science, July 31, 1992; 257(5070): 682 - 685.
[Abstract] [PDF]

Home page
 ScienceHome page
D. Webb, Y Shimizu, G. Van Seventer, S Shaw, and T. Gerrard
LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release
Science, September 14, 1990; 249(4974): 1295 - 1297.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.